Share Your Research, Maximize Your Social Impacts
A NEW IN THE TREATMENT OF UNRESECTABLE OR METASTATIC MELANOMA
Journal: Synergy of Science (Vol.14, No. 1)Publication Date: 2017-08-31
Authors : Galyaveeva A.R.;
Page : 0-0
Keywords : Pembrolizumab; melanoma; tumor; survival; clinical trial.;
Source : Download
Find it from : Google Scholar
Abstract
Pembrolizumab is a new medicine in the Treatment of Unresectable or Metastatic Melanoma. Pembrolizumab is a monoclonal antibody that binds to the PD-1 receptor and blocks interaction with its ligands, PD-L1 and PD-L2. This binding results in the activation of T-cell–mediated immune responses against tumor cells
Other Latest Articles
- THE ANALYSIS OF MODERN CRYPTO ALGORITHMS AND THE ESTIMATION OF THEIR CRYPTO STRENGHT
- PENGARUH PARTISIPASI PEMAKAI DAN DUKUNGAN MANAJEMEN PUNCAK TERHADAP KESUKSESAN PENGEMBANGAN SISTEM INFORMASI AKUNTANSI SERTA DAMPAKNYA TERHADAP PROSES PENGAMBILAN KEPUTUSAN
- PENGARUH OBJEKTIVITAS DAN INTEGRITAS AUDITOR INTERNAL TERHADAP KUALITAS AUDIT
- ANALISIS PERSEPSI AUDITOR MENGENAI FAKTOR PENENTU AUDIT FEE BERDASARKAN CLIENT ATTRIBUTES, AUDITOR ATTRIBUTES, DAN ENGAGEMENT ATRTRIBUTES
- PENGARUH PENERAPAN E-GOVERNMENT TERHADAP PELAKSANAAN TATA KELOLA PEMERINTAH DI PEMERINTAH KABUPATEN CIANJUR
Last modified: 2017-08-14 23:25:43